Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the ...

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

Dr. Boris Naraev, a medical oncologist specializing in patient care for those suffering from gastrointestinal, neuroendocrine ...

Belle Gibson claimed to have cured her cancer through healthy eating and alternative therapies, but it was all a lie - and ...

Researchers analyzed data on 215 women diagnosed with stages 0-III breast cancer between January 2000 and October 2024 who ...

Researchers surveyed survivors of early-stage hormone receptor-positive breast cancer who did not receive chemotherapy to assess the symptom burden in this patient population.

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Donald Patrick McDonnell, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer, the ...

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.